Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. (Q44497007)
scientific article published in July 2003
Language:
(P31) (Q13442814)
(P50) (Q73094399)
(Q44616312)
(P304) 194-196
(P407) (Q1860)
(P433) 1
(P478) 136
(P577) Tuesday, July 1, 2003
(P921) (Q111140)
(Q18556689)
(P1433) (Q4744258)
(P1476) "Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas" (language: en)
(P2093) Ali Erginay
Pascale Massin
Paul Scigalla
Stéphane Richard
(P2860) (Q40643124)
(Q73948185)
(Q33914433)
(Q31107435)
other details
description scientific article published in July 2003

External Links